Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-01-19 Tax Withholding | 2021-01-19 6:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration | 1,685 | $6.68 | 116,062 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:37 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration | 54,334 | $0 | 150,747 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 4:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration | 2,739 | $5.8 | 150,747 (Direct) | View |
| 2020-09-15 Option Award | 2020-09-16 5:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration | 4,500 | $0 | 97,873 (Direct) | View |
| 2020-09-15 Tax Withholding | 2020-09-16 5:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration | 1,557 | $6.25 | 97,873 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-03 5:47 pm | 2021-03-31 2030-03-31 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-19 Tax Withholding | 2020-01-21 5:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration | 2,044 | $7.18 | 92,840 (Direct) | View |
| 2020-01-03 Option Award | 2020-01-03 8:03 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration | 40,000 | $0 | 40,000 (Direct) | View |